AbbVie is planning to launch its ovarian cancer drug in the U.K. at the U.S. price. This is in line with President Trump’s most favored nations policy which demands that drugmakers align domestic ...

In a Truth Social post, Trump noted that the White House would place a 100% tariff on “any branded or patented” pharmaceutical product — unless a company was investing in manufacturing facilities in ...

This week, the FDA began the process of approving leucovorin as a treatment for autism, despite a lack of any large, phase 3 clinical trials.

With the Trump administration scaling back federal efforts to protect Americans from medical bills they can’t pay, advocates for patients and consumers have shifted their work to contain the nation’s ...

When the FDA demands a new standard of balance in how benefits and risks are communicated, it should be framed against the larger backdrop of what harms Americans every day.

Working with agency partner DCX Growth Accelerator, GeneDX takes direct aim at the issue of underdiagnosis of pediatric rare diseases.

With the Trump administration scaling back federal efforts to protect Americans from medical bills they can’t pay, advocates for patients and consumers have shifted their work to contain the nation’s ...

When the FDA demands a new standard of balance in how benefits and risks are communicated, it should be framed against the larger backdrop of what harms Americans every day.

Today, although only a small subset of HCPs uses social primarily for creation, those who do have significant sway. Sixty-six percent of consumers interact with HCP influencers — more than relevant ...

The Trump administration is continuing its push to revise federal guidelines to delay the hepatitis B vaccine newborn dose for most children.

Even if people qualify for financial help with their hospital bills, the care they receive may not be covered.

The 100% pharma tariff threat; Drugmakers make moves ahead of MFN deadline; RFK Jr. mulls adding autism symptoms to vaccine injury program.